CTRI/2024/02/062929已完成4 期
A post market clinical follow up prospective study to evaluate safety and performance of Sodium Hyaluronate 0.2% Eye Drops - NI
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 54
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Subjects who are able to give voluntary, written informed consent to participate in this study.
- •Subjects who experience eye dryness, Eye Soreness/ burning, Irritative Sensation, Eye fatigue, contact lens caused dryness, discomfort of eyes due to the continuous use of computer/ TV/
- •exposed pollution/ dry environment
排除标准
- •Anyone with known allergic reaction to Sodium Hyaluronate 0.2% Eye Drops.
- •Subjects with existing eye infection
- •History of ocular surgery. History or active signs of severe or serious ocular conditions such as inflammatory corneal ulcers, recurrent erosions, and uveitis at any time
- •Patients participating in any another clinical trial during study
- •Pregnant/lactating women during study period.
研究者
相似试验
尚未招募
4 期
A study to evaluate safety and performance of Hydroxypropyl Methylcellulose Eye DropsCTRI/2024/06/069121Kilitch Healthcare India Ltd.
尚未招募
4 期
A study to evaluate safety and performance of Sodium Hyaluronate Ophthalmic SolutioCTRI/2024/06/068514Kilitch Healthcare India Ltd.
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations - Sodium Chloride Eye Drop (0.75%) (Calendula extract plus Hamamelis extractCTRI/2022/07/043790STERICON PHARMA PRIVATE LIMITED72
已完成
4 期
The purpose of the study is to evaluate safety and performance of Eye Preparations - HPMC EYE WASH (Hydroxy Propyl Methyl Cellulose Eye Wash )CTRI/2022/07/043794STERICON PHARMA PRIVATE LIMITED72
已完成
4 期
the study is to evaluate safety and performance of Eye Preparations - Distilled Witch Hazel eye washCTRI/2022/07/043857Stericon Pharma Private Limited72